The 2018 midterm elections have evolved into an ultimatum on one critical policy issue: Medicare for all.
Across the country, Bernie Sanders acolytes are rising in Congressional and gubernatorial races. As a result, experts believe the pressures from left-leaning groups could turn the 2020 election into a referendum on universal healthcare in the United States.
That also means investors are closely watching the healthcare industry, which is already in the middle of a dramatic shift over the last two years.
Mergers between pharmaceutical companies and health insurance firms have altered the market for managed healthcare. These hybrid firms are completely changing the healthcare landscape by streamlining patient care, making it easier to access, and upping profit margins in the process.
That's why we aren't worried about any competition from the government. In fact, expanded Medicare will shovel even more money into these companies.
And we have identified a way for you to make a fortune while the rest of Wall Street sits on their hands waiting to see what happens in November.
In fact, this company's products and services are in high demand in the $7 trillion global healthcare industry.
And its stock is now officially ready for blastoff...
Medicine has shifted over the last two decades from a reactive practice to one that emphasizes prevention and early detection.
At the center of this transition has been the increased innovation and detective qualities of clinical laboratory services.
If you're smart, you get your blood tested every six months to check for critical markers, including cholesterol, testosterone levels, and blood inflammation levels.
LIVE ON CAMERA: Watch America's No. 1 Pattern Trader officially become $1,050 richer in 15 seconds! His secret to becoming a multimillionaire is so easy that anybody can do it. Click here for details...
You see, simple blood tests have dramatically improved your doctors' abilities to prevent, detect, and treat minor to serious conditions ranging from cardiovascular, diabetes, and blood disorders.
This testing has exploded as a high-demand, high-growth industry.
And if you're looking to capture your share, we're about to unveil our top pick in the sector...
If you're looking to get your share of a booming, global growth story, look no further than Laboratory Corp. of America Holdings (NYSE: LH).
The Burlington, North Carolina-based company operates the largest network of clinical laboratories in the world. Its U.S. network has 36 labs and processes 2.5 million lab tests every week.
The company was an early pioneer in the booming industry for genome testing, and it performs testing in oncology and human immunodeficiency virus (HIV) genotyping and phenotyping.
But there's one reason that the LH stock price is really set to surge...
Laboratory Corp. is now the contracted laboratory provider for every major health insurance company in the United States. It is the exclusive national lab partner for all UnitedHealth Group Inc. (NYSE: UNH) customers.
This is the largest health insurance company in the country with roughly 49 million members.
Starting on Jan. 1, 2019, it will become the newest in-network lab partner for Aetna Inc. (NYSE: AET). This adds another 22.1 million medical members to its base, plus another 12.7 million dental members.
But there's even more to like about LH stock...
[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]
As we dig through the diagnostic report - the financial numbers - of this company, we see a stock poised for even higher returns. LabCorp is extremely sound from a financial standpoint.
Its Piotroski F-Score - which measures a company's financial health on a scale of 0 to 9 - comes in at a very healthy 8. This score measures its profitability, leverage and liquidity, and operating efficiency.
Click here to see all of our top-rated stocks, and you'll automatically get free updates on our top stocks, based on our proprietary rating system, the Money Morning Stock VQScore™.
The diagnostic check reveals a firm that has plenty of capital to address its liabilities.
But the real number that stands out is the Money Morning Stock VQScore™ it registered this week. Our proprietary VQScore says that Laboratory Holdings has a perfect 4, making it a perfect "Buy Now" candidate.
It's no wonder analysts are giving LabCorp a high price target of $220 a share, 29% higher than its current price of $171.13 a share.
But the VQScore system doesn't limit itself to mere double-digit returns, so we think Wall Street is being way too conservative about this stock.
We monitor more than 1,500 public companies, and only a select few reach this level. And when you're sitting on a perfect score, you know that you're getting one of the best buys in the market today. The VQScore system has a solid history of predicting and delivering triple-digit - and even quadruple-digit - winners time and time again.
Just look at Solaredge Technnologies Inc. (NASDAQ: SEDG), which rocketed 267% in the year after it hit a perfect 4 VQScore.
Or consider TAL Education Group ADR (NYSE: TAL). It exploded for 2,573% gains since hitting a perfect score in May 2013.
In fact, the VQScore system identified 48 triple-digit winners over the last five years.
Don't worry about which way the healthcare market will turn in the future.
Bureaucrats and insurance companies both want control.
But at the end of the day, we're tapping into the real demand for preventative medicine and the hundreds of billions available for us to tap into for life-changing gains.
And then $940 RICHER in 11 seconds...
$1,260 RICHER in eight seconds... and $988 RICHER in seven seconds!
You've never seen anything like this. And you may never see it again!
His secret to becoming a multimillionaire is so easy that anybody can do it!
Click here to get all the details...
Follow Money Morning on Facebook, Twitter, and LinkedIn.
